Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - SHORT-TERM DEBT
Short-term Debt PRPH - ProPhase Labs, Inc.
2.79 M
LAST VALUE
45.13%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR